Healthcare Sector Struggles, Yet These Yields Reaching 7% Might Still Be Viable
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 29 2025
0mins
Source: NASDAQ.COM
Healthcare Stocks Overview
- Market Performance: Healthcare stocks have remained stagnant since April, contrasting sharply with the S&P 500, which has surged by 27%. This stagnation has drawn the attention of contrarian investors looking for potential bargains or yield traps in the sector.
Key Healthcare Stocks
Omega Healthcare Investors (OHI): Offers a 6.4% yield and operates skilled nursing and assisted living facilities with a portfolio of 93,961 beds across over 1,000 properties. The company has shown recovery post-COVID, beating estimates for adjusted funds from operations (AFFO) and raising its full-year guidance. However, shares are trading at over 13 times next year's AFFO estimates, indicating a moderate valuation.
LTC Properties (LTC): With a 6.3% yield, LTC is transitioning some contracts to RIDEA-structured agreements, which could enhance growth potential. Currently, 7% of its enterprise value comes from this segment, with plans to double it by year-end.
Healthpeak Properties (DOC): This REIT has a 7.0% yield and a diverse portfolio including outpatient medical facilities and laboratories. The dividend was recently raised and converted to a monthly payout, but growth may be limited due to challenges in its life sciences segment.
Sila Realty Trust (SILA): A newer entrant with a 6.4% yield, SILA has delivered nearly 20% total returns since its IPO in June 2024. It has a solid financial position with long lease terms and a well-covered payout, although it reverted from a monthly to a quarterly dividend.
Pharmaceutical Sector Insights
Siga Technologies (SIGA): Offers a high yield of 7.1%, but is considered too concentrated as a single-drug company. Its future growth depends on diversification.
Bristol-Myers Squibb (BMY): A blue-chip pharmaceutical company with a market cap of nearly $100 billion and a 5.3% yield. Despite its diversified product line, BMY has underperformed, with a 25% decline in share price over five years. However, it recently beat earnings estimates and is forming strategic partnerships.
Pfizer (PFE): Currently yielding 6.9%, Pfizer has faced challenges, including the cancellation of a weight-loss drug trial and declining COVID-related sales. The company is targeting $7 billion in cost savings by 2027, but its dividend remains secure for now with a 55% payout ratio.
Investment Strategy
- Retirement Income Strategy: The article emphasizes the importance of generating income through dividends to avoid depleting capital in retirement. A proposed "No Withdrawal" portfolio could yield $40,000 annually from a $500,000 investment, highlighting the potential for high-yield investments to support retirement without touching the principal.
This analysis suggests that while healthcare stocks have been overlooked, there are opportunities for income-focused investors, particularly in REITs and select pharmaceutical companies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SILA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SILA
Wall Street analysts forecast SILA stock price to fall
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 30.240
Low
28.00
Averages
28.00
High
28.00
Current: 30.240
Low
28.00
Averages
28.00
High
28.00
About SILA
Sila Realty Trust, Inc. is a real estate investment trust. The Company is primarily focused on investing in high-quality healthcare facilities across the continuum of care, which the Company believes typically generates predictable, durable and growing income streams. Its portfolio comprises tenants in geographically diverse facilities, which are positioned to capitalize on the dynamic delivery of healthcare to patients. The Company owns approximately 136 real estate properties, and two undeveloped land parcels located in 66 markets across the United States. Its portfolio includes Akron Healthcare Facility, Alexandria Healthcare Facility, Allen Healthcare Facility, Appleton Healthcare Facility, Augusta Healthcare Facility, Beaumont Healthcare Facility, Bellevue Healthcare Facility, Carrollton Healthcare Facility, Cincinnati Healthcare Facility, Yukon Healthcare Facility, El Segundo Healthcare Facility, Dallas Healthcare Facility, Pleasant Hills Healthcare Facility, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Select Medical Holdings Corporation's sale to a consortium led by executives at $16.50 per share, raising concerns about potential violations of shareholder rights and urging shareholders to understand their options.
- Merger Scrutiny: The merger of Envirotech Vehicles, Inc. with AZIO AI Corp. is also under investigation, with Halper Sadeh LLC encouraging Envirotech shareholders to reach out to learn about their legal rights, ensuring they are not overlooked during the merger process.
- Real Estate Transaction Review: The sale of Sila Realty Trust, Inc. to Blue Owl Real Estate Capital LLC for $30.38 per share is similarly scrutinized, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures to protect shareholder interests.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, meaning shareholders do not have to pay out-of-pocket legal fees when addressing these matters, ensuring all shareholders can defend their rights without financial burden.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Rights Protection: Monteverde & Associates is investigating the transaction between AvalonBay Communities, Inc. and Equity Residential, where AvalonBay shareholders are expected to receive 2.793 shares of Equity Residential common stock for each share held, impacting shareholder equity structure significantly.
- Merger Impact Analysis: Following the merger, Equity Residential shareholders will own approximately 48.8% of the combined entity, a shift that could alter market dynamics and influence investor strategies moving forward.
- Cash Acquisition Proposal: Shareholders of Select Medical Holdings Corporation are expected to receive $16.50 per share in cash, with a shareholder vote scheduled for June 26, 2026, providing immediate cash returns to investors and enhancing shareholder value.
- Real Estate Transaction Dynamics: Sila Realty Trust, Inc. shareholders are anticipated to receive $30.38 in cash per share, with voting also set for June 26, 2026, further driving consolidation and growth in the real estate market.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. (NYSE:SILA) regarding its sale to Blue Owl Real Estate Capital LLC at $30.38 per share, potentially infringing on shareholder rights, aiming to ensure fair treatment for investors.
- UniFirst Shareholder Rights Concern: UniFirst Corporation (NYSE:UNF) is being sold for $155.00 in cash and 0.7720 shares of Cintas stock per share, with Halper Sadeh LLC potentially advocating for higher transaction prices and additional disclosures to protect shareholder interests.
- Assertio Holdings Transaction Review: Assertio Holdings, Inc. (NASDAQ:ASRT) is selling to Garda Therapeutics for $18.00 per share in cash plus a contingent value right, and Halper Sadeh LLC is assessing whether this deal serves the best interests of shareholders, possibly seeking increased compensation.
- Kennedy-Wilson Transaction Risks: Kennedy-Wilson Holdings, Inc. (NYSE:KW) is being sold for $10.90 per share in cash to a consortium led by CEO William McMorrow, with Halper Sadeh LLC potentially representing shareholders to seek better terms and transparency to safeguard their investments.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. (NYSE:SILA) for its sale to Blue Owl Real Estate Capital LLC at $30.38 per share, raising concerns about potential shareholder rights violations and encouraging shareholders to explore their options.
- Acquisition Terms: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is being sold to Chiesi Group for $27.00 per share in cash, with Halper Sadeh LLC potentially seeking increased consideration to ensure fair compensation for shareholders.
- Transaction Options: Thermon Group Holdings, Inc. (NYSE:THR) is proposed to be sold to CECO Environmental Corp., offering shareholders a choice between cash and stock combinations or $63.89 per share in cash, with Halper Sadeh LLC advocating for better terms on behalf of shareholders.
- Legal Support: Lisata Therapeutics, Inc. (NASDAQ:LSTA) is selling to Kuva Labs, Inc. for $4.00 per share, and Halper Sadeh LLC provides no-cost legal consultations to help shareholders understand their rights and options, ensuring their legal interests are protected.
See More
Investigation Alerts for Multiple Company Mergers
- KalVista Merger Investigation: KalVista Pharmaceuticals is set to be acquired by Chiesi Group for $27.00 per share, implying a total value of approximately $1.9 billion, with investigations focusing on whether the board breached fiduciary duties by failing to conduct a fair process.
- Thermon Acquisition Review: Thermon Group Holdings will be acquired by CECO Environmental in a deal valued at around $2.2 billion, allowing shareholders to choose between cash and stock, with investigations into potential breaches of fiduciary duties by the board regarding fair treatment of shareholders.
- Sila Realty Acquisition Inquiry: Sila Realty Trust is to be acquired by Blue Owl Capital for $30.38 per share, totaling approximately $2.4 billion, with investigations examining whether the board failed to ensure a fair process and fair value for shareholders.
- Lisata Therapeutics Merger Scrutiny: Lisata Therapeutics will be acquired by Kuva Labs for $4.00 per share plus contingent value rights, with investigations into whether the board breached fiduciary duties by not ensuring fair value in the transaction for shareholders.
See More
Sila Realty Trust Declares Quarterly Dividend of $0.40
- Quarterly Dividend Announcement: Sila Realty Trust declares a quarterly dividend of $0.40 per share, consistent with previous distributions, indicating the company's stable cash flow and shareholder return strategy, which is expected to bolster investor confidence.
- Dividend Yield: The forward yield of 5.23% makes this dividend attractive in the current market environment, potentially drawing in income-seeking investors and enhancing the company's competitive position within the Real Estate Investment Trust (REIT) sector.
- Financial Performance: Sila Realty Trust reports a GAAP EPS of $0.22 and revenue of $52.66 million, reflecting the company's ongoing growth potential in the high-yield healthcare real estate sector, despite facing AFFO headwinds, growth drivers are gradually aligning.
- Market Dynamics: The recent acquisition activities of Sila Realty Trust highlight that many REITs are still trading at a discount, potentially offering investors an opportunity to enter high-yield assets, further driving market interest in the company.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Select Medical Holdings Corporation's sale to a consortium led by executives at $16.50 per share, raising concerns about potential violations of shareholder rights and urging shareholders to understand their options.
- Merger Scrutiny: The merger of Envirotech Vehicles, Inc. with AZIO AI Corp. is also under investigation, with Halper Sadeh LLC encouraging Envirotech shareholders to reach out to learn about their legal rights, ensuring they are not overlooked during the merger process.
- Real Estate Transaction Review: The sale of Sila Realty Trust, Inc. to Blue Owl Real Estate Capital LLC for $30.38 per share is similarly scrutinized, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures to protect shareholder interests.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, meaning shareholders do not have to pay out-of-pocket legal fees when addressing these matters, ensuring all shareholders can defend their rights without financial burden.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Rights Protection: Monteverde & Associates is investigating the transaction between AvalonBay Communities, Inc. and Equity Residential, where AvalonBay shareholders are expected to receive 2.793 shares of Equity Residential common stock for each share held, impacting shareholder equity structure significantly.
- Merger Impact Analysis: Following the merger, Equity Residential shareholders will own approximately 48.8% of the combined entity, a shift that could alter market dynamics and influence investor strategies moving forward.
- Cash Acquisition Proposal: Shareholders of Select Medical Holdings Corporation are expected to receive $16.50 per share in cash, with a shareholder vote scheduled for June 26, 2026, providing immediate cash returns to investors and enhancing shareholder value.
- Real Estate Transaction Dynamics: Sila Realty Trust, Inc. shareholders are anticipated to receive $30.38 in cash per share, with voting also set for June 26, 2026, further driving consolidation and growth in the real estate market.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation Launched: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. (NYSE:SILA) regarding its sale to Blue Owl Real Estate Capital LLC at $30.38 per share, potentially infringing on shareholder rights, aiming to ensure fair treatment for investors.
- UniFirst Shareholder Rights Concern: UniFirst Corporation (NYSE:UNF) is being sold for $155.00 in cash and 0.7720 shares of Cintas stock per share, with Halper Sadeh LLC potentially advocating for higher transaction prices and additional disclosures to protect shareholder interests.
- Assertio Holdings Transaction Review: Assertio Holdings, Inc. (NASDAQ:ASRT) is selling to Garda Therapeutics for $18.00 per share in cash plus a contingent value right, and Halper Sadeh LLC is assessing whether this deal serves the best interests of shareholders, possibly seeking increased compensation.
- Kennedy-Wilson Transaction Risks: Kennedy-Wilson Holdings, Inc. (NYSE:KW) is being sold for $10.90 per share in cash to a consortium led by CEO William McMorrow, with Halper Sadeh LLC potentially representing shareholders to seek better terms and transparency to safeguard their investments.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Focus: Halper Sadeh LLC is investigating Sila Realty Trust, Inc. (NYSE:SILA) for its sale to Blue Owl Real Estate Capital LLC at $30.38 per share, raising concerns about potential shareholder rights violations and encouraging shareholders to explore their options.
- Acquisition Terms: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is being sold to Chiesi Group for $27.00 per share in cash, with Halper Sadeh LLC potentially seeking increased consideration to ensure fair compensation for shareholders.
- Transaction Options: Thermon Group Holdings, Inc. (NYSE:THR) is proposed to be sold to CECO Environmental Corp., offering shareholders a choice between cash and stock combinations or $63.89 per share in cash, with Halper Sadeh LLC advocating for better terms on behalf of shareholders.
- Legal Support: Lisata Therapeutics, Inc. (NASDAQ:LSTA) is selling to Kuva Labs, Inc. for $4.00 per share, and Halper Sadeh LLC provides no-cost legal consultations to help shareholders understand their rights and options, ensuring their legal interests are protected.
See More
Investigation Alerts for Multiple Company Mergers
- KalVista Merger Investigation: KalVista Pharmaceuticals is set to be acquired by Chiesi Group for $27.00 per share, implying a total value of approximately $1.9 billion, with investigations focusing on whether the board breached fiduciary duties by failing to conduct a fair process.
- Thermon Acquisition Review: Thermon Group Holdings will be acquired by CECO Environmental in a deal valued at around $2.2 billion, allowing shareholders to choose between cash and stock, with investigations into potential breaches of fiduciary duties by the board regarding fair treatment of shareholders.
- Sila Realty Acquisition Inquiry: Sila Realty Trust is to be acquired by Blue Owl Capital for $30.38 per share, totaling approximately $2.4 billion, with investigations examining whether the board failed to ensure a fair process and fair value for shareholders.
- Lisata Therapeutics Merger Scrutiny: Lisata Therapeutics will be acquired by Kuva Labs for $4.00 per share plus contingent value rights, with investigations into whether the board breached fiduciary duties by not ensuring fair value in the transaction for shareholders.
See More
Sila Realty Trust Declares Quarterly Dividend of $0.40
- Quarterly Dividend Announcement: Sila Realty Trust declares a quarterly dividend of $0.40 per share, consistent with previous distributions, indicating the company's stable cash flow and shareholder return strategy, which is expected to bolster investor confidence.
- Dividend Yield: The forward yield of 5.23% makes this dividend attractive in the current market environment, potentially drawing in income-seeking investors and enhancing the company's competitive position within the Real Estate Investment Trust (REIT) sector.
- Financial Performance: Sila Realty Trust reports a GAAP EPS of $0.22 and revenue of $52.66 million, reflecting the company's ongoing growth potential in the high-yield healthcare real estate sector, despite facing AFFO headwinds, growth drivers are gradually aligning.
- Market Dynamics: The recent acquisition activities of Sila Realty Trust highlight that many REITs are still trading at a discount, potentially offering investors an opportunity to enter high-yield assets, further driving market interest in the company.
See More
